Shortcut Navigation:

Breast Cancer News

In this section, access cutting-edge breast cancer news on treatment updates, emerging therapies, study results and other medical and quality-of-life issues important to you.

Calif. insurer won't pay for breast cancer drug

(Reuters) - Health insurer Blue Shield of California has decided not to pay for Roche Holding's drug Avastin to treat breast cancer after health advisers said it was not safe or clinically beneficial.

Novartis's Afinitor shows promise in breast cancer

STOCKHOLM (Reuters) - Combining two drugs from Novartis and Pfizer to treat post-menopausal women with a certain type of advanced breast cancer more than doubled the time they lived without their disease getting worse, study data showed on Monday.

Breast cancer study shows benefits of double therapy

STOCKHOLM (Reuters) - Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk their tumors will come back and should be considered as a new treatment approach across the world, cancer experts said on Sunday.

Poor women get more unneeded breast cancer surgery

NEW YORK (Reuters Health) - Old, poor and Hispanic women are all more likely to have lymph nodes under the armpit removed unnecessarily during breast cancer surgery, a new study finds.

Plant-rich diets tied to lower breast cancer risk

NEW YORK (Reuters Health) - Women with diets rich in vegetables, fruit and legumes may have a somewhat decreased risk of developing one type of breast cancer, a new study suggests.

Treatment Options for ER-positive Breast Cancer

The first head-to-head comparison of two aromatase inhibitors showed the treatments had similar outcomes in overall survival and recurrence prevention but one had less impact than the other on bone and heart health.

New breast cancer gene may help predict risk

NEW YORK (Reuters Health) - Screening for mutations in a gene known as CHEK2 may help determine a woman's odds of breast cancer if the disease runs in her family, Polish scientists suggested Monday.

Genetic cancer test often urged for wrong women

NEW YORK (Reuters Health) - Doctors are too quick to recommend expensive genetic counseling or testing for ovarian cancer, but at the same time often fail to refer high-risk women, government researchers say.

Can "biofield healing" relieve cancer fatigue?

NEW YORK (Reuters Health) - A new study suggests that "biofield healing" -- and in some cases, even fake versions of the energy-field therapy -- may help ease fatigue in breast cancer survivors.

Cancer disparities exist despite good insurance

NEW YORK (Reuters Health) - Despite having equal access to health care through military health insurance, black women with breast cancer are less likely than white women to receive certain aggressive treatments, according to the findings of a new study.